Capital Fund Management S.A. Sarepta Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

$37.9 Billion
Q4 2024

A detailed history of Capital Fund Management S.A. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 173,745 shares of SRPT stock, worth $18.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

173,745

Previous 204,146 14.89%

Holding current value

$18.5 Million

Previous $25.5 Million 17.15%

% of portfolio

0.06%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$104.54 - $137.94 $3.18 Million - $4.19 Million	-30,401 Reduced 14.89%	173,745 $21.1 Million
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $25.4 Million - $32 Million	204,146 New	204,146 $25.5 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $3.36 Million - $5.07 Million	-35,815 Reduced 47.31%	39,881 $5.16 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $5.1 Million - $9.44 Million	75,696 New	75,696 $7.3 Million
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $1.31 Million - $1.84 Million	-20,855 Reduced 58.12%	15,028 $1.13 Million
Q1 2022 May 12, 2022	BUY	$63.15 - $90.42 $1.17 Million - $1.67 Million	18,471 Added 106.08%	35,883 $2.8 Million
Q4 2021 Feb 10, 2022	BUY	$77.28 - $99.42 $1.35 Million - $1.73 Million	17,412 New	17,412 $1.57 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $922,839 - $1.7 Million	-9,923 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $166,489 - $266,044	-2,021 Reduced 16.92%	9,923 $970,000
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $347,369 - $615,397	4,539 Added 61.3%	11,944 $1.54 Million
Q2 2019 Aug 12, 2019	BUY	$112.21 - $151.95 $626,468 - $848,336	5,583 Added 306.42%	7,405 $1.13 Million
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $4.93 Million - $7.01 Million	-46,218 Reduced 96.21%	1,822 $217,000
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $1.14 Million - $2.43 Million	15,842 Added 49.2%	48,040 $6.35 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $2.1 Million - $3.2 Million	-38,938 Reduced 54.74%	32,198 $2.39 Million
Q4 2017 Feb 09, 2018	BUY	$47.64 - $56.75 $3.13 Million - $3.73 Million	65,738 Added 1217.82%	71,136 $3.96 Million
Q3 2017 Nov 13, 2017	BUY	$35.73 - $47.15 $192,870 - $254,515	5,398	5,398 $245,000

Others Institutions Holding SRPT

# of Institutions

536

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.31B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Sarepta Therapeutics, Inc. Transaction History